Bacillary Angiomatosis: What to Do When Initial Antibiotic Therapy Has Not Achieved an Adequate Serological Response

This protocol is for patients with Bacillary angiomatosis who have undergone a first-line antibiotic course but have not met the expected serological response threshold — requiring a structured next-line approach.

Prior treatment & failure condition

The initial regimen consisted of doxycycline or erythromycin as preferred options, or azithromycin or clarithromycin as alternatives, each continued for at least 3 months. Failure is defined as the absence of a fourfold or greater decrease in anti-Bartonella IFA IgG antibody titers on sequential endpoint titration, assessed every 6 to 8 weeks during treatment.

Next-line approach (partial overview)

For patients who do not respond adequately, switching to a different preferred antibiotic regimen is a considered strategy — the full protocol defines the specific agents, required duration, and monitoring framework.

Instant Access to Structured Evidence-Based Regimens

References

Among patients who fail to respond to initial treatment, switching to a different preferred regimen (for example, from doxycycline to erythromycin) may be considered, again with treatment duration of ≥3 months (AIII).

View source ↗